In a first, the United States Food and Drug Administration has approved an oral tablet called baricitinib for the treatment of alopecia. Alopecia, which is an autoimmune disorder affecting more than 300,000 people in the United States every year, which leads to emotional distress and causes either temporary or permanent patchy hair loss that can affect any hair-bearing site of the body.

US FDA approves first oral tablet called baricitinib for treatment of alopecia

Drug major Natco Pharma on Monday said, it has received emergency use approval for Baricitinib tablets, for the treatment of COVID-19 positive patients, from the Central Drugs Standard Control Organisation (CDSCO) in India.

Natco gets CDSCO nod for emergency use of Baricitinib tablets for COVID-19 treatment 

baricitinib

Baricitinib, News on Baricitinib, stories on Baricitinib, articles on Baricitinib, Baricitinib stories at Wion, Baricitinib news, Baricitinib latest news